newsfilter
← Latest News
Business Wire·

AlloVir to Present at the 40th Annual J.P. Morgan Healthcare Conference

AlloVir (NASDAQ:ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, at 4